ROS and intracellular ion channels

Cell Calcium

Volumn 60, Issue 2, 2016, Pages 108-114

  Kiselyov, Kirill ^a,b   Muallem, Shmuel ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Calcium; Endoplasmic reticulum; Ion channels; Lysosomes; Oxidative stress; Reactive oxygen species; Transition metals

Indexed keywords

CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ION CHANNEL; MENKES PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRANSITION ELEMENT; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN; ZNT PROTEIN; CALCIUM;

CALCIUM TRANSPORT; CELL FUNCTION; CELL MEMBRANE; ENDOPLASMIC RETICULUM; HUMAN; LYSOSOME; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; INTRACELLULAR SPACE; ION TRANSPORT; METABOLISM; MITOCHONDRION;

ANIMALS; CALCIUM; HUMANS; INTRACELLULAR SPACE; ION CHANNELS; ION TRANSPORT; MITOCHONDRIA; MODELS, BIOLOGICAL;

EID: 84961145629     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2016.03.004     Document Type: Review

References (137)

1. [1] Xia, Z., Chen, Y., Fan, Q., Xue, M., Oxidative stress-mediated reperfusion injury: mechanism and therapies. Oxid. Med. Cell. Longevity, 2014, 2014, 373081.
2. [2] Rodriguez-Rodriguez, A., Egea-Guerrero, J.J., Murillo-Cabezas, F., Carrillo-Vico, A., Oxidative stress in traumatic brain injury. Curr. Med. Chem. 21 (2014), 1201–1211.
3. [3] Kalogeris, T., Bao, Y., Korthuis, R.J., Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2 (2014), 702–714.
4. [4] Repnik, U., Stoka, V., Turk, V., Turk, B., Lysosomes and lysosomal cathepsins in cell death. Biochim. Biophys. Acta 1824 (2012), 22–33.
5. [5] Ott, M., Gogvadze, V., Orrenius, S., Zhivotovsky, B., Mitochondria, oxidative stress and cell death. Apoptosis 12 (2007), 913–922.
6. [6] Baird, S.K., Kurz, T., Brunk, U.T., Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem. J. 394 (2006), 275–283.
7. [7] Van Beersel, G., Tihon, E., Demine, S., Hamer, I., Jadot, M., Arnould, T., Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts. Biosci. Rep., 33, 2013, e00023.
8. [8] Coblentz, J., St Croix, C., Kiselyov, K., Loss of TRPML1 promotes production of reactive oxygen species: is oxidative damage a factor in mucolipidosis type IV?. Biochem. J. 457 (2014), 361–368.
9. [9] Kurz, T., Terman, A., Gustafsson, B., Brunk, U.T., Lysosomes in iron metabolism, ageing and apoptosis. Histochem. Cell. Biol. 129 (2008), 389–406.
10. [10] Allen, C.L., Bayraktutan, U., Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke 4 (2009), 461–470.
11. [11] Yoshioka, M., Tanaka, K., Miyazaki, I., Fujita, N., Higashi, Y., Asanuma, M., Ogawa, N., The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals. Neurosci. Res. 43 (2002), 259–267.
12. [12] Robinson, N.J., Winge, D.R., Copper metallochaperones. Annu. Rev. Biochem. 79 (2010), 537–562.
13. [13] Miller, M.W., Sadeh, N., Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis. Mol. Psychiatry 19 (2014), 1156–1162.
14. [14] Hare, D., Ayton, S., Bush, A., Lei, P., A delicate balance: iron metabolism and diseases of the brain. Front. Aging Neurosci., 5, 2013, 34.
15. [15] Terman, A., Dalen, H., Eaton, J.W., Neuzil, J., Brunk, U.T., Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Annu. N.Y. Acad. Sci. 1019 (2004), 70–77.
16. [16] Zheng, Z., Lee, J.E., Yenari, M.A., Stroke: molecular mechanisms and potential targets for treatment. Curr. Mol. Med. 3 (2003), 361–372.
17. [17] Cojocaru, I.M., Cojocaru, M., Sapira, V., Ionescu, A., Evaluation of oxidative stress in patients with acute ischemic stroke. Rom. J. Intern. Med. 51 (2013), 97–106.
18. [18] Neri, M., Fineschi, V., Di Paolo, M., Pomara, C., Riezzo, I., Turillazzi, E., Cerretani, D., Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr. Vasc. Pharmacol. 13 (2015), 26–36.
19. [19] Cornelius, C., Crupi, R., Calabrese, V., Graziano, A., Milone, P., Pennisi, G., Radak, Z., Calabrese, E.J., Cuzzocrea, S., Traumatic brain injury: oxidative stress and neuroprotection. Antioxid. Redox Signal. 19 (2013), 836–853.
20. [20] Scheiber, I.F., Mercer, J.F., Dringen, R., Metabolism and functions of copper in brain. Prog. Neurobiol. 116 (2014), 33–57.
21. [21] Yu, J.H., Kim, H., Oxidative stress and inflammatory signaling in cerulein pancreatitis. World J. Gastroenterol. 20 (2014), 17324–17329.
22. [22] Baffy, G., Derdak, Z., Robson, S.C., Mitochondrial recoupling: a novel therapeutic strategy for cancer?. Br. J. Cancer 105 (2011), 469–474.
23. [23] Drose, S., Brandt, U., Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv. Exp. Med. Biol. 748 (2012), 145–169.
24. [24] Schafer, M.K., Pfeiffer, A., Jaeckel, M., Pouya, A., Dolga, A.M., Methner, A., Regulators of mitochondrial Ca(2+) homeostasis in cerebral ischemia. Cell Tissue Res. 357 (2014), 395–405.
25. [25] Szydlowska, K., Tymianski, M., Calcium, ischemia and excitotoxicity. Cell Calcium 47 (2010), 122–129.
26. [26] Liou, A.K., Clark, R.S., Henshall, D.C., Yin, X.M., Chen, J., To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog. Neurobiol. 69 (2003), 103–142.
27. [27] Brunk, U.T., Jones, C.B., Sohal, R.S., A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat. Res. 275 (1992), 395–403.
28. [28] Grishchuk, Y., Peña, K.A., Coblentz, J., King, V.E., Humphrey, D.M., Wang, S.L., Kiselyov, K.I., Slaugenhaupt, S.A., Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV. Dis. Models Mech., 8, 2015 1591–601.
29. [29] Sensi, S.L., Paoletti, P., Koh, J.Y., Aizenman, E., Bush, A.I., Hershfinkel, M., The neurophysiology and pathology of brain zinc. J. Neurosci. 31 (2011), 16076–16085.
30. [30] Lee, S.J., Park, M.H., Kim, H.J., Koh, J.Y., Metallothionein-3 regulates lysosomal function in cultured astrocytes under both normal and oxidative conditions. Glia 58 (2010), 1186–1196.
31. [31] Lee, S.J., Koh, J.Y., Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol. Brain, 3, 2010, 30.
32. [32] Granzotto, A., Sensi, S.L., Intracellular zinc is a critical intermediate in the excitotoxic cascade. Neurobiol. Dis. 81 (2015), 25–37.
33. [33] Brito, R., Castillo, G., Gonzalez, J., Valls, N., Rodrigo, R., Oxidative stress in hypertension: mechanisms and therapeutic opportunities. Exp. Clin. Endocrinol. Diabetes 123 (2015), 325–335.
34. [34] Lee, S.J., Cho, K.S., Koh, J.Y., Oxidative injury triggers autophagy in astrocytes: the role of endogenous zinc. Glia 57 (2009), 1351–1361.
35. [35] Wang, F., Reece, E.A., Yang, P., Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy. Am. J. Obstet. Gynecol. 213 (2015), 125–134.
36. [36] Luczak, E.D., Anderson, M.E., CaMKII oxidative activation and the pathogenesis of cardiac disease. J. Mol. Cell. Cardiol. 73 (2014), 112–116.
37. [37] Takahashi, N., Kozai, D., Kobayashi, R., Ebert, M., Mori, Y., Roles of TRPM2 in oxidative stress. Cell Calcium 50 (2011), 279–287.
38. [38] Veit, F., Pak, O., Brandes, R.P., Weissmann, N., Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels. Antioxid. Redox Signal 22 (2015), 537–552.
39. [39] Syed Mortadza, S.A., Wang, L., Li, D., Jiang, L.H., TRPM2 channel-mediated ROS-sensitive Ca(2+) signaling mechanisms in immune cells. Front. Immunol., 6, 2015, 407.
40. [40] Olschewski, A., Weir, E.K., Redox regulation of ion channels in the pulmonary circulation. Antioxid. Redox Signal. 22 (2015), 465–485.
41. [41] Gamper, N., Ooi, L., Redox and nitric oxide-mediated regulation of sensory neuron ion channel function. Antioxid. Redox Signal. 22 (2015), 486–504.
42. [42] Sesti, F., Wu, X., Liu, S., Oxidation of KCNB1 K(+) channels in central nervous system and beyond. World J. Biol. Chem. 5 (2014), 85–92.
43. [43] Sahoo, N., Hoshi, T., Heinemann, S.H., Oxidative modulation of voltage-gated potassium channels. Antioxid. Redox Signal. 21 (2014), 933–952.
44. [44] Kozai, D., Ogawa, N., Mori, Y., Redox regulation of transient receptor potential channels. Antioxid. Redox Signal. 21 (2014), 971–986.
45. [45] Hidalgo, C., Donoso, P., Crosstalk between calcium and redox signaling: from molecular mechanisms to health implications. Antioxid. Redox Signal. 10 (2008), 1275–1312.
46. [46] Donoso, P., Sanchez, G., Bull, R., Hidalgo, C., Modulation of cardiac ryanodine receptor activity by ROS and RNS. Front. Biosci. (Landmark Ed.) 16 (2011), 553–567.
47. [47] Vervloessem, T., Yule, D.I., Bultynck, G., Parys, J.B., The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca(2)(+)-release channel. Biochim. Biophys. Acta 1853 (2015), 1992–2005.
48. [48] Mikoshiba, K., Role of IP3 receptor signaling in cell functions and diseases. Adv. Biol. Regul. 57 (2015), 217–227.
49. [49] Mak, D.O., Foskett, J.K., Inositol 1,4,5-trisphosphate receptors in the endoplasmic reticulum: a single-channel point of view. Cell Calcium 58 (2015), 67–78.
50. 2+ spikes in HeLa cells by sensitizing the inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 267 (1992), 25113–25119.
51. [51] Joseph, S.K., Ryan, S.V., Pierson, S., Renard-Rooney, D., Thomas, A.P., The effect of mersalyl on inositol trisphosphate receptor binding and ion channel function. J. Biol. Chem. 270 (1995), 3588–3593.
52. [52] Renard-Rooney, D.C., Joseph, S.K., Seitz, M.B., Thomas, A.P., Effect of oxidized glutathione and temperature on inositol 1 4,5-trisphosphate binding in permeabilized hepatocytes. Biochem. J. 310:Pt 1 (1995), 185–192.
53. 2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem. Pharmacol. 67 (2004), 491–502.
54. [54] Zheng, Y., Shen, X., H2O2 directly activates inositol 1,4,5-trisphosphate receptors in endothelial cells. Redox Rep. 10 (2005), 29–36.
55. 2+ mobilization in pulmonary arterial smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007), L1598–1608.
56. [56] Bansaghi, S., Golenar, T., Madesh, M., Csordas, G., RamachandraRao, S., Sharma, K., Yule, D.I., Joseph, S.K., Hajnoczky, G., Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species. J. Biol. Chem. 289 (2014), 8170–8181.
57. [57] Madesh, M., Hawkins, B.J., Milovanova, T., Bhanumathy, C.D., Joseph, S.K., Ramachandrarao, S.P., Sharma, K., Kurosaki, T., Fisher, A.B., Selective role for superoxide in InsP3 receptor-mediated mitochondrial dysfunction and endothelial apoptosis. J. Cell Biol. 170 (2005), 1079–1090.
58. [58] Massaad, C.A., Klann, E., Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid. Redox Signal. 14 (2011), 2013–2054.
59. [59] Annunziata, I., d'Azzo, A., Interorganellar membrane microdomains: dynamic platforms in the control of calcium signaling and apoptosis. Cells 2 (2013), 574–590.
60. [60] Grimm, S., The ER-mitochondria interface: the social network of cell death. Biochim. Biophys. Acta 1823 (2012), 327–334.
61. [61] Van Petegem, F., Ryanodine receptors: allosteric ion channel giants. J. Mol. Biol. 427 (2015), 31–53.
62. [62] Eisner, D., Calcium in the heart: from physiology to disease. Exp. Physiol. 99 (2014), 1273–1282.
63. [63] Amador, F.J., Stathopulos, P.B., Enomoto, M., Ikura, M., Ryanodine receptor calcium release channels: lessons from structure-function studies. FEBS J. 280 (2013), 5456–5470.
64. [64] Niggli, E., Ullrich, N.D., Gutierrez, D., Kyrychenko, S., Polakova, E., Shirokova, N., Posttranslational modifications of cardiac ryanodine receptors: ca(2+) signaling and EC-coupling. Biochim. Biophys. Acta 1833 (2013), 866–875.
65. 2+ release channel (RyR1): sites and nature of oxidative modification. J. Biol. Chem. 288 (2013), 22961–22971.
66. [66] Andersson, D.C., Betzenhauser, M.J., Reiken, S., Meli, A.C., Umanskaya, A., Xie, W., Shiomi, T., Zalk, R., Lacampagne, A., Marks, A.R., Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 14 (2011), 196–207.
67. [67] Santulli, G., Xie, W., Reiken, S.R., Marks, A.R., Mitochondrial calcium overload is a key determinant in heart failure. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 11389–11394.
68. 2+ and redox modification of ryanodine receptor channels from rat brain cortex. J. Neurosci. 28 (2008), 9463–9472.
69. 2+ handling in ageing rabbit hearts. J. Physiol. 591 (2013), 5895–5911.
70. [70] Wang, Q., Wang, W., Wang, G., Rodney, G.G., Wehrens, X.H., Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy. J. Mol. Cell Cardiol. 89 (2015), 177–184.
71. 2+ release via ROS-stimulated ryanodine receptors. PLoS One, 10, 2015, e0129238.
72. [72] Contreras-Ferrat, A., Llanos, P., Vasquez, C., Espinosa, A., Osorio-Fuentealba, C., Arias-Calderon, M., Lavandero, S., Klip, A., Hidalgo, C., Jaimovich, E., Insulin elicits a ROS-activated and an IP(3)-dependent Ca(2)(+) release, which both impinge on GLUT4 translocation. J. Cell Sci. 127 (2014), 1911–1923.
73. 2+ pumps of the endoplasmic reticulum and golgi apparatus. Cold Spring Harb. Perspect. Biol., 3, 2011.
74. [74] Lancel, S., Qin, F., Lennon, S.L., Zhang, J., Tong, X., Mazzini, M.J., Kang, Y.J., Siwik, D.A., Cohen, R.A., Colucci, W.S., Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice. Circ. Res. 107 (2010), 228–232.
75. [75] Adachi, T., Matsui, R., Xu, S., Kirber, M., Lazar, H.L., Sharov, V.S., Schoneich, C., Cohen, R.A., Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ. Res. 90 (2002), 1114–1121.
76. [76] Greensmith, D.J., Eisner, D.A., Nirmalan, M., The effects of hydrogen peroxide on intracellular calcium handling and contractility in the rat ventricular myocyte. Cell Calcium 48 (2010), 341–351.
77. 2+ entry dependent contraction of coronary artery smooth muscle: inhibition by peroxide pretreatment. Cell Calcium 51 (2012), 149–154.
78. 2+ pump in endothelium: implications to coronary artery function. Am. J. Physiol. 273 (1997), C1250–1258.
79. [79] Schweigel-Rontgen, M., The families of zinc (SLC30 and SLC39) and copper (SLC31) transporters. Curr. Top Membr. 73 (2014), 321–355.
80. [80] Valerio, L.G., Mammalian iron metabolism. Toxicol. Mech. Methods 17 (2007), 497–517.
81. [81] Huang, L., Tepaamorndech, S., The SLC30 family of zinc transporters—a review of current understanding of their biological and pathophysiological roles. Mol. Aspects Med. 34 (2013), 548–560.
82. [82] Kambe, T., Molecular architecture and function of ZnT transporters. Curr. Top Membr. 69 (2012), 199–220.
83. [83] Mlyniec, K., Singewald, N., Holst, B., Nowak, G., GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?. J. Affect. Disord. 174 (2015), 89–100.
84. [84] Mlyniec, K., Zinc in the glutamatergic theory of depression. Curr. Neuropharmacol. 13 (2015), 505–513.
85. [85] Koh, J.Y., Choi, D.W., Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience 60 (1994), 1049–1057.
86. [86] Bouron, A., Kiselyov, K., Oberwinkler, J., Permeation regulation and control of expression of TRP channels by trace metal ions. Pflugers Arch., 467, 2014 1143–64.
87. [87] Manev, H., Kharlamov, E., Uz, T., Mason, R.P., Cagnoli, C.M., Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Exp. Neurol. 146 (1997), 171–178.
88. [88] Nolte, C., Gore, A., Sekler, I., Kresse, W., Hershfinkel, M., Hoffmann, A., Kettenmann, H., Moran, A., ZnT-1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc. Glia 48 (2004), 145–155.
89. [89] S.R. Hennigar, Y.A. Seo, S. Sharma, D.I. Soybel, S.L. Kelleher, ZnT2 is a critical mediator of lysosomal-mediated cell death during early mammary gland involution, Science Reports in press 5, 2015, 8033.
90. [90] Seo, Y.A., Kelleher, S.L., Functional analysis of two single nucleotide polymorphisms in SLC30A2 (ZnT2): implications for mammary gland function and breast disease in women. Physiol. Genomics 42A (2010), 219–227.
91. [91] McCormick, N.H., Hennigar, S.R., Kiselyov, K., Kelleher, S.L., The biology of zinc transport in mammary epithelial cells: implications for mammary gland development, lactation, and involution. J. Mammary Gland Biol. Neoplasia 19 (2014), 59–71.
92. [92] Laity, J.H., Andrews, G.K., Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch. Biochem. Biophys. 463 (2007), 201–210.
93. [93] Saydam, N., Adams, T.K., Steiner, F., Schaffner, W., Freedman, J.H., Regulation of metallothionein transcription by the metal-responsive transcription factor MTF-1: identification of signal transduction cascades that control metal-inducible transcription. J. Biol. Chem. 277 (2002), 20438–20445.
94. [94] Andrews, G.K., Cellular zinc sensors: mTF-1 regulation of gene expression. Biometals 14 (2001), 223–237.
95. [95] Thirumoorthy, N., Shyam Sunder, A., Manisenthil Kumar, K., Senthil Kumar, M., Ganesh, G., Chatterjee, M., A review of metallothionein isoforms and their role in pathophysiology. World J. Surg. Oncol., 9, 2011, 54.
96. [96] Maret, W., Krezel, A., Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol. Med. 13 (2007), 371–375.
97. [97] Polishchuk, E.V., Concilli, M., Iacobacci, S., Chesi, G., Pastore, N., Piccolo, P., Paladino, S., Baldantoni, D., van, I.S.C., Chan, J., Chang, C.J., Amoresano, A., Pane, F., Pucci, P., Tarallo, A., Parenti, G., Brunetti-Pierri, N., Settembre, C., Ballabio, A., Polishchuk, R.S., Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev. Cell, 2014.
98. [98] Harada, M., Kawaguchi, T., Kumemura, H., Terada, K., Ninomiya, H., Taniguchi, E., Hanada, S., Baba, S., Maeyama, M., Koga, H., Ueno, T., Furuta, K., Suganuma, T., Sugiyama, T., Sata, M., The Wilson disease protein ATP7B resides in the late endosomes with Rab7 and the Niemann-Pick C1 protein. Am. J. Pathol. 166 (2005), 499–510.
99. [99] Lutsenko, S., Bhattacharjee, A., Hubbard, A.L., Copper handling machinery of the brain. Metallomics 2 (2010), 596–608.
100. [100] Xie, L., Collins, J.F., Transcription factors Sp1 and Hif2 alpha mediate induction of the copper-transporting ATPase (Atp7a) gene in intestinal epithelial cells during hypoxia. J. Biol. Chem. 288 (2013), 23943–23952.
101. [101] Xie, L., Collins, J.F., Transcriptional regulation of the Menkes copper ATPase (Atp7a) gene by hypoxia-inducible factor (HIF2{alpha}) in intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 300 (2011), C1298–1305.
102. [102] Ji, C., Kosman, D.J., Molecular mechanisms of non-transferrin-bound and transferring-bound iron uptake in primary hippocampal neurons. J. Neurochem. 133 (2015), 668–683.
103. [103] Terman, A., Brunk, U.T., Lipofuscin. Int. J. Biochem. Cell Biol. 36 (2004), 1400–1404.
104. [104] Qian, Z.M., Wu, X.M., Fan, M., Yang, L., Du, F., Yung, W.H., Ke, Y., Divalent metal transporter 1 is a hypoxia-inducible gene. J. Cell Physiol. 226 (2011), 1596–1603.
105. [105] Csordas, G., Hajnoczky, G., SR/ER-mitochondrial local communication: calcium and ROS. Biochim. Biophys. Acta 1787 (2009), 1352–1362.
106. [106] Waring, P., Redox active calcium ion channels and cell death. Arch. Biochem. Biophys. 434 (2005), 33–42.
107. 2+ signaling. Antioxid. Redox Signal. 14 (2011), 1225–1235.
108. [108] Li, Z., Ji, G., Neugebauer, V., Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior. J. Neurosci. 31 (2011), 1114–1127.
109. [109] Ho, H.T., Liu, B., Snyder, J.S., Lou, Q., Brundage, E.A., Velez-Cortes, F., Wang, H., Ziolo, M.T., Anderson, M.E., Sen, C.K., Wehrens, X.H., Fedorov, V.V., Biesiadecki, B.J., Hund, T.J., Gyorke, S., Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides. Cardiovasc. Res. 101 (2014), 165–174.
110. [110] Peña, K.A., Kiselyov, K., Transition metals activate TFEB in overpexpressing cells. Biochem. J. 470 (2015), 65–76.
111. 2+-induced toxicity. J. Cell Sci. 127 (2014), 3094–3103.
112. [112] Hawkins, B.J., Madesh, M., Kirkpatrick, C.J., Fisher, A.B., Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Mol. Biol. Cell 18 (2007), 2002–2012.
113. [113] Liu, J., Zhang, F.F., Li, L., Yang, J., Liu, J., Guan, Y.Y., Du, Y.H., ClC-3 deficiency prevents apoptosis induced by angiotensin II in endothelial progenitor cells via inhibition of NADPH oxidase. Apoptosis 18 (2013), 1262–1273.
114. [114] Fisher, A.B., Redox signaling across cell membranes. Antioxid. Redox Signal. 11 (2009), 1349–1356.
115. [115] Dong, X.P., Cheng, X., Mills, E., Delling, M., Wang, F., Kurz, T., Xu, H., The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455 (2008), 992–996.
116. [116] Wang, W., Zhang, X., Gao, Q., Xu, H., TRPML1: an ion channel in the lysosome. Handb. Exp. Pharmacol. 222 (2014), 631–645.
117. [117] Moos, T., Skjoerringe, T., Gosk, S., Morgan, E.H., Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J. Neurochem. 98 (2006), 1946–1958.
118. [118] Moos, T., Morgan, E.H., The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J. Neurochem. 88 (2004), 233–245.
119. [119] Burdo, J.R., Menzies, S.L., Simpson, I.A., Garrick, L.M., Garrick, M.D., Dolan, K.G., Haile, D.J., Beard, J.L., Connor, J.R., Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res 66 (2001), 1198–1207.
120. [120] Cheng, X., Zhang, X., Gao, Q., Ali Samie, M., Azar, M., Tsang, W.L., Dong, L., Sahoo, N., Li, X., Zhuo, Y., Garrity, A.G., Wang, X., Ferrer, M., Dowling, J., Xu, L., Han, R., Xu, H., The intracellular Ca(2)(+) channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy. Nat. Med. 20 (2014), 1187–1192.
121. [121] Samie, M., Wang, X., Zhang, X., Goschka, A., Li, X., Cheng, X., Gregg, E., Azar, M., Zhuo, Y., Garrity, A.G., Gao, Q., Slaugenhaupt, S., Pickel, J., Zolov, S.N., Weisman, L.S., Lenk, G.M., Titus, S., Bryant-Genevier, M., Southall, N., Juan, M., Ferrer, M., Xu, H., A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev. Cell 26 (2013), 511–524.
122. [122] Laplante, J.M., Sun, M., Falardeau, J., Dai, D., Brown, E.M., Slaugenhaupt, S.A., Vassilev, P.M., Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol. Genet. Metab. 89 (2006), 339–348.
123. 4 (Slc30a4) transporter. Biochem. J. 451 (2013), 155–163.
124. [124] Eichelsdoerfer, J.L., Evans, J.A., Slaugenhaupt, S.A., Cuajungco, M.P., Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel. J. Biol. Chem. 285 (2010), 34304–34308.
125. [125] Cuajungco, M.P., Basilio, L.C., Silva, J., Hart, T., Tringali, J., Chen, C.C., Biel, M., Grimm, C., Cellular zinc levels are modulated by TRPML1-TMEM163 interaction. Traffic 15 (2014), 1247–1265.
126. [126] Weiss, N., Cross-talk between TRPML1 channel, lipids and lysosomal storage diseases. Commun. Integr. Biol. 5 (2012), 111–113.
127. [127] Zhang, X., Li, X., Xu, H., Phosphoinositide isoforms determine compartment-specific ion channel activity. Proc. Natl. Acad. Sci. U. S. A., 109, 2012 11384–9.
128. [128] Vucicevic, L., Misirkic-Marjanovic, M., Paunovic, V., Kravic-Stevovic, T., Martinovic, T., Ciric, D., Maric, N., Petricevic, S., Harhaji-Trajkovic, L., Bumbasirevic, V., Trajkovic, V., Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine. Autophagy 10 (2014), 2362–2378.
129. [129] Miao, Y., Li, G., Zhang, X., Xu, H., Abraham, S.N., A TRP channel senses lysosome neutralization by pathogens to trigger their expulsion. Cell 161 (2015), 1306–1319.
130. [130] Venkatachalam, K., Wong, C.O., Zhu, M.X., The role of TRPMLs in endolysosomal trafficking and function. Cell Calcium 58 (2014), 48–56.
131. [131] Curcio-Morelli, C., Charles, F.A., Micsenyi, M.C., Cao, Y., Venugopal, B., Browning, M.F., Dobrenis, K., Cotman, S.L., Walkley, S.U., Slaugenhaupt, S.A., Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol. Dis. 40 (2010), 370–377.
132. [132] Martina, J.A., Lelouvier, B., Puertollano, R., The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway. Traffic 10 (2009), 1143–1156.
133. [133] Vergarajauregui, S., Connelly, P.S., Daniels, M.P., Puertollano, R., Autophagic dysfunction in mucolipidosis type IV patients. Hum. Mol. Genet. 17 (2008), 2723–2737.
134. [134] Saldanha, S.A., Grimm, C., Mercer, B.A., Choi, J.Y., Allais, C., Roush, W.R., Heller, S., Hodder, P., Campaign to Identify Agonists of Transient Receptor Potential Channels 3 and 2 (TRPML3 & TRPML2)., 2010, Probe Reports from the NIH Molecular Libraries Program, Bethesda (MD).
135. [135] Chen, C.C., Keller, M., Hess, M., Schiffmann, R., Urban, N., Wolfgardt, A., Schaefer, M., Bracher, F., Biel, M., Wahl-Schott, C., Grimm, C., A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV. Nat. Commun., 5, 2014, 4681.
136. [136] Saldanha, S.A., Grimm, C., Allais, C., Smith, E., Ouizem, S., Mercer, B.A., Roush, W.R., Heller, S., Hodder, P., Identification of Selective Agonists of the Transient Receptor Potential Channels 3 (TRPML3)., 2010, Probe Reports from the NIH Molecular Libraries Program, Bethesda (MD).
137. [137] Grimm, C., Jors, S., Saldanha, S.A., Obukhov, A.G., Pan, B., Oshima, K., Cuajungco, M.P., Chase, P., Hodder, P., Heller, S., Small molecule activators of TRPML3. Chem. Biol. 17 (2010), 135–148.